brain metastases

BOSTON, July 22, 2026 Verastem Oncology has announced that the first patient has been dosed in the TARGET-D 202...

PITTSBURGH, Pa., July 23, 2026 Xodus Medical has announced encouraging results from a new observational clinical study demonstrating that...

LONDON, United Kingdom, July 23, 2026 GSK plc has announced that the U.S. Food and Drug Administration (FDA) has...

TEMPE, Ariz., May 30, 2026 GT Medical Technologies announced positive Phase 3 results from the randomized multicenter ROADS clinical...

FLORENCE, Italy and NEW YORK, May 28, 2026 Menarini Group and its wholly owned subsidiary Stemline Therapeutics have announced...

CHICAGO, Illinois, May 29, 2026 Johnson & Johnson has reported landmark results from the pivotal Phase 3 MajesTEC-9 study,...

CHICAGO, Illinois, May 31, 2026 Akeso, Inc. has announced landmark results from the pivotal Phase III HARMONi-6 trial, demonstrating...

May 31, 2026 – Chicago, Illinois, USA Dizal has unveiled encouraging clinical findings for two innovative non-small cell lung...

CAMBRIDGE, Mass., April 17, 2026 Nuvalent, Inc. has reported compelling clinical and preclinical data for its investigational drug zidesamtinib,...

SYDNEY, April 16, 2026 Radiopharmaceutical innovation continues to reshape oncology diagnostics as Radiopharm Theranostics announced completion of enrollment in...